Portfolio data

Browse all portfolio data news

    Latest portfolio data news

    Show news from

    Achilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022

    Achilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022

    Freeline Reports Third Quarter 2022 Financial Results and Corporate Update

    Anaveon presents updated data from the Phase I/II study of ANV419 during the SITC Annual Meeting

    Anaveon presents updated data from the Phase I/II study of ANV419 during the ESMO Congress 2022

    New England Journal of Medicine Publishes Positive Long-Term Data on Freeline’s Gene Therapy Candidate FLT180a for People with Hemophilia B

    Load more

    Search